Metabolite details
Reactome pathways
- No Reactome pathways listed for this metabolite.
Observed in studies
- Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
- Multi-Omics Analysis Reveals Disturbance of Nanosecond Pulsed Electric Field in the Serum Metabolic Spectrum and Gut Microbiota
- Collagen induced arthritis in dba/1j mice associates with oxylipin changes in plasma
- Efficacy of Zhuyu Pill Intervention in a Cholestasis Rat Model: Mutual Effects on Fecal Metabolism and Microbial Diversity
- Lipid mediators of inflammation in BALF 3-19 days after infection with influenza.
- Lipid mediators of inflammation in BALF 6-19 days after infection with influenza.
- Lipid mediators of inflammation in BALF 3-11 days after infection with influenza.
- Lipid mediators of inflammation in BALF 3-13 days after infection with influenza.
- Intergenerational Association of Gut Microbiota and Metabolism between Perinatal Folic Acid Metabolism and Neural Tube Defects (Feces metabolomics)
- Mechanism of interventional effect and targets of Zhuyu Pill in regulating and suppressing colitis and cholestasis
- TGF-β uncouples glycolysis and inflammation in macrophages and controls the survival during sepsis
- Unraveling the metabolic effects of benzophenone-3 on the endosymbiotic dinoflagellate Cladocopium goreaui
Observed in differential profiles
- G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
- Control_vs_nsPEF_7_day
- Control_vs_CIA
- Control_vs_CF_high
- Mock_18_days_vs_X31_19_days
- Mock_19d_vs_PR8_19d
- G1_Mock_11_day_vs_G5_PR8_11_day
- Mock_13d_vs_PR8_13d
- Normal_vs_Neural_Tube_Defect
- Control_vs_ZYP_High_Dose
- Control_vs_TGF-beta_Treatment
- Control_vs_BP3_Low_Concentration